Refine your search:     
Report No.

Assessment of equivalent dose of the lens of the eyes and the extremities to workers under nonhomogeneous exposure situation in nuclear and accelerator facilities by means of measurements using a phantom coupled with Monte Carlo simulation

Yoshitomi, Hiroshi; Hagiwara, Masayuki*; Kowatari, Munehiko; Nishino, Sho; Sanami, Toshiya*; Iwase, Hiroshi*

The equivalent doses to the lens of the eye and extremities for radiation workers should be assessed properly to ensure that the dose limits are not exceeded. Recently, the following two issues has pressed demand on more appropriate evaluation of the equivalent doses of the lens of the eye and extremity. One is the new occupational dose limit for the lens of the eye the ICRP recommended. The other is growing demand on handling of highly activated materials in the maintenance works of an accelerator and contaminated materials during the decommissioning works of nuclear facility, which increases the potential exposure risk to the extremities to a wider variety of radio-nuclides. Since the points to be assessed for the exposures to the lens of the eye and the extremities are apart from the trunk, the homogeneity of the radiation fields would be significantly impact on the assessment of these equivalent doses. However, there has been no sufficient and available method to identify the nonhomogeneous situations systematically in terms of the eye lens or extremity monitoring. The goal of this study is to provide the framework to identify the nonhomogeneous exposure situations. In order to fulfil this purpose, newly proposed indices to represent the homogeneity were calculated by Monte Carlo simulation incorporated with mathematical phantom, verifying the benchmark measurements. Important parameters that significantly impact on these indices were also shown from the various trials of calculations of homogeneity indices.



- Accesses





[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.